Could common drugs stop dangerous sugar crashes?
NCT ID NCT05174507
Summary
This study aimed to see if two existing drugs could help people with prediabetes who experience dangerous drops in blood sugar after eating. It planned to test empagliflozin (a diabetes drug) and anakinra (an anti-inflammatory drug) against a placebo. The goal was to reduce the number and severity of these low blood sugar episodes. However, the study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPRANDIAL HYPOGLYCEMIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.